SHR1210
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SHR1210, covering 2019-06-14 to 2021-03-10. Get the full timeline:
Most recent: Clinical Trial Update: a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer [Phase 2]